Genitourinary Cancers Steering Committee
The Genitourinary Steering Committee (GUSC) was established in 2008. The GUSC is currently composed of the Steering Committee and three task forces (Prostate Cancer, Bladder Cancer, and Renal Cancer). Members of the GUSC include representatives from the Cooperative Groups with active genitourinary programs, representatives from the prostate, renal, and bladder Specialized Programs of Research Excellence (SPORE) and other translational scientists, community oncologists, biostatisticians, pathologists, patient advocates, and NCI staff.
The GUSC functions to harmonize an efficient, cost-effective, science-driven, and transparent process that will identify and promote the "Best Science" in genitourinary cancer clinical research by addressing the design and prioritization of phase III trials and large phase II studies.
Roster of Genitourinary Steering Committee (GUSC) members
Robert Dreicer, M.D., Eric Klein, M.D., and Anthony Zietman, M.D., Co-chairs
- Prostate Cancer: Deborah A. Kuban, M.D., Charles J. Ryan, M.D., Andrew Stephenson, M.D. Co-chairs
- Bladder Cancer: Dean Bajorin, M.D., Jason A. Efstathiou, M.D., Ph.D. and Seth Lerner, M.D. Co-chairs
- Renal Cancer: Christopher Kane, M.D., Brian Rini, M.D., Victor Reuter, M.D. Co-chairs
Clinical Trial Planning Meetings (CTPMs): Goal of Clinical Trial Planning Meetings, and List of CTPM Executive Summaries and Publications
To search all active clinical trials, go to: http://www.cancer.gov/clinicaltrials/search
CCCT Contact: Abdul Tawab-Amiri, Ph.D.